Anti‐Inflammatory Nanotherapeutics by Targeting Matrix Metalloproteinases for Immunotherapy of Spinal Cord InjuryKui Shen, Tianfeng Chen, Jia‐Run Huang et al.|Small|2021Cited by 70
Recruitment of γδ T cells to the lesion via the CCL2/CCR2 signaling after spinal cord injuryPing Xu, Guodong Sun, Feng Zhang et al.|Journal of Neuroinflammation|2021Cited by 52
Spinal cord injury target-immunotherapy with TNF-α autoregulated and feedback-controlled human umbilical cord mesenchymal stem cell derived exosomes remodelled by CRISPR/Cas9 plasmidBaocheng Wang, Guodong Sun, Minmin Chang et al.|Biomaterials Advances|2021Cited by 49
Anti‐Inflammatory Nanotherapeutics by Targeting Matrix Metalloproteinases for Immunotherapy of Spinal Cord Injury (Small 41/2021)Kui Shen, Tianfeng Chen, Minmin Chang et al.|Small|2021Cited by 0